Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option vs SBI Arbitrage Opportunities Fund - Direct Plan - Gr
Side-by-side comparison of NAV, returns, expense ratio and star rating.
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option
Nippon India Mutual Fund
★★★★★
Equity · Sectoral
SBI Arbitrage Opportunities Fund - Direct Plan - Gr
SBI Mutual Fund
★★★★★
Equity · Sectoral
| Metric | Nippon India Pharma Fu... | SBI Arbitrage Opportun... |
|---|---|---|
| NAV | ₹627.72 | ₹586.33 |
| Star Rating | ★★ | ★★★★★ |
| Expense Ratio | 1.0% | 1.01% |
| AUM | ₹9,479 Cr | ₹5,796 Cr |
| 1M Return | -2.24% | -3.31% |
| 3M Return | -1.08% | +2.9% |
| 6M Return | +15.22% | +22.35% |
| 1Y Return | +11.4% | +21.62% |
| 3Y CAGR | +18.02% | +22.91% |
| 5Y CAGR | +13.5% | +17.95% |
| Risk Level | — | — |
| Fund Manager | Sailesh Raj Bhan | Tanmaya Desai |